SecBot SecBot
144 ·Filed Jun 24, 2026

CGON

CG Oncology, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago SEC0001950047-26-006467
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine, small-dollar insider sale by a director under a 10b5-1 plan. No material signal for the stock. Monitor for any acceleration of insider selling or changes in the 10b5-1 plan, but this filing alone does not warrant a trading response.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$72.84
T+0 close · Jun 24, 2026 · via day close
Latest settled
+2.44%
T+60 · $74.62
Vs SPY
−1.29%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 25 $72.84entry
  2. T+1 · 5mo ago −1.21%α −0.48% · $71.96
  3. T+5 · 5mo ago −2.68%α −4.24% · $70.89
  4. T+20 · 4mo ago −2.36%α −2.89% · $71.12
  5. T+60 · 8w ago +2.44%α −1.29% · $74.62
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Leonard Post filed a Form 144 notice of intent to sell 5,000 shares of CG Oncology common stock, with an estimated aggregate market value of $328,650. The shares are to be acquired through the exercise of stock options, and the sale is planned under a Rule 10b5-1 trading plan. This is a routine insider sale by a director, not a top executive, and the dollar amount is small relative to the company's $6.1B market cap.

Key Facts

  • Director Leonard Post filed Form 144 on June 24, 2026, indicating intent to sell 5,000 shares.
  • Estimated aggregate market value of the proposed sale is $328,650.
  • Shares are to be acquired upon exercise of stock options; sale is part of a pre-arranged 10b5-1 plan.
  • The sale represents a tiny fraction of the company's $6.1B market cap.
  • Prior 30-day insider activity includes 3 sells totaling $419K, consistent with routine option exercise/sale patterns.

Financial Impact

Proposed sale of 5,000 shares valued at ~$328,650, representing less than 0.01% of market cap.

dilution

Risk Factors

  • Insider selling could accelerate if the 10b5-1 plan is expanded or if other insiders follow suit.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
91% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-006467
Document: 0001950047-26-006467-index.html0001950047-26-006467
Document: 0001950047-26-006467.txt0001950047-26-006467

Track record

25 reports on CGON

Performance horizon

6 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +26.33% at T+20 after the Jun 12, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today 8-K Bullish 7/10 Entry $98.84 Now $84.78 −14.23% settles Dec 15
  2. Nov 16, 2026today Press Release Bullish 7/10 Entry $95.01 Now $84.78 −10.77% settles Dec 15
  3. Nov 6, 202610d ago 8-K Bearish 5/10 Entry $75.99 Now $84.78 −11.57% settles Dec 7
  4. Nov 6, 202610d ago Press Release Neutral 4/10 Entry $75.99 Now $84.78 +11.57% settles Dec 7
  5. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $64.06 Now $84.78 +32.34% settles Dec 2
  6. Oct 19, 202628d ago 3 Neutral 2/10 Entry $61.93 Now $84.78 +36.90% settles Nov 17
  7. Oct 15, 20264w ago 144 Neutral 2/10 Entry $59.85 to $74.40 Now $84.78 +41.65% ▲ +24.31% +25.47% vs SPY
  8. Oct 12, 20265w ago Institutional Cluster Mixed 3/10 Entry $63.13 to $74.74 Now $84.78 +34.29% ▲ +18.39% +21.66% vs SPY
  9. Aug 6, 202614w ago Press Release Bearish 7/10 Entry $74.85 to $74.33 Now $84.78 −13.27% ▲ +0.69% +1.29% vs SPY
  10. Aug 6, 202614w ago 424B5 Bearish 6/10 Entry $74.85 to $74.33 Now $84.78 −13.27% ▲ +0.69% +1.29% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens in 6h 22m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 24, 2026